Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Leonard Patrick Gage | M | 81 |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 9 years |
| Pierre F. Dodion | M | 69 | - | |
| Edward Fitzgerald | M | 68 | 14 years | |
| Athanase Lavidas | M | 75 | 13 years | |
| Lee C. Steele | M | 75 | 1 years | |
| Laurie A. Allen | F | 63 | 9 years | |
| Robert Kamen | M | 79 |
BASF Bioresearch Corp.
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 18 years |
| Melissa A. Kelly Behrs | F | 59 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 8 years |
| Klaus Schollmeier | M | 67 |
BASF Bioresearch Corp.
| 4 years |
| Stephen Albert Martin | M | 54 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 5 years |
| John W. Loewy | M | - | - | |
| Shirish Hirani | M | - | 12 years | |
| Gustav Christensen | M | 76 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 5 years |
| Jane F. Amara | M | - | 7 years | |
| Joseph P. Dougherty | M | - |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 4 years |
| Joseph Bratica | M | 60 | 22 years | |
| Michael Fisher | M | - |
BASF Bioresearch Corp.
| 3 years |
| Tao Guo | M | - | 3 years | |
| Cristina Csimma | M | 65 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 12 years |
| Kelly M. Schmitz | M | - | 1 years | |
| William Shakespeare | M | 60 | 21 years | |
| Chester A. Metcalf | M | - | 15 years | |
| Christopher Murray | M | 61 | 13 years | |
| Maryann G. Krane | F | 64 | - | |
| Brett L. Schmidli | M | 72 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 7 years |
| Camille Bedrosian | M | 71 | 6 years | |
| Peter J. Licari | M | 60 |
BASF Bioresearch Corp.
| 3 years |
| Zoltan A. Csimma | M | 82 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 10 years |
| Mary C. Tanner | F | 73 | - | |
| Paul Sekhri | M | 66 | 1 years | |
| Michael Gilman | M | 69 | 5 years | |
| Mark J. Zoller | M | 70 | 7 years | |
| Richard Pascoe | M | 60 | 3 years | |
| R. Greer | M | 65 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 6 years |
| Marc Goldberg | M | 67 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 4 years |
| Burton E. Sobel | M | 86 | 6 years | |
| Thomas D. Kiley | M | 80 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 8 years |
| Michael Kishbauch | M | 75 | 4 years | |
| Robert H. Tidwell | M | 80 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 5 years |
| James E. Vath | M | 62 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 7 years |
| Elizabeth Hamilton Seabury Wyatt | M | 76 | 6 years | |
| Timothy Clackson | M | 58 | 23 years | |
| Stephanie Pearl | F | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 43 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David L. Berstein
- Personal Network
